Lymphoma Treatment in Hyderabad
Reviewed June 2026 · Dr. Madhav Danthala
Lymphoma arises in the lymphatic system — not as a single tumour in one organ, but often as disease across lymph nodes, marrow, and blood. The first fork is Hodgkin versus non-Hodgkin, and they are treated very differently. Most lymphomas are among the most treatable cancers, with options spanning chemotherapy, rituximab-based immunotherapy, radiation, transplant, and CAR-T therapy.
Dr. Madhav Danthala is a hemato-oncologist and BMT physician with fellowship training in leukemia and transplant at Vancouver General Hospital, Canada. He has performed 300+ bone marrow transplants and consults at KIMS-Sunshine Hospitals, Begumpet.
"Lymphoma" covers dozens of diseases. Whether it is Hodgkin or non-Hodgkin, and aggressive or indolent, decides everything about the plan.
When to See a Doctor
Most swollen glands are infections, and most settle within a few weeks. The pattern that warrants attention is a lump that is painless, persistent, and growing — especially alongside the cluster doctors call "B symptoms."
A persistent, painless lump
A node in the neck, armpit, or groin that does not settle after 2–4 weeks, is painless, and feels rubbery or is enlarging deserves evaluation — even if you feel well.
Drenching night sweats & fever
Soaking the bedclothes at night, or unexplained fevers that come and go over weeks, are classic "B symptoms" that should prompt a check.
Unintentional weight loss
Losing more than about 10% of body weight over six months without trying — the third B symptom — is worth investigating, lymphoma or not.
Persistent itching or fatigue
Itching without a rash, persistent fatigue, or feeling full quickly (from an enlarged spleen) can accompany lymphoma and are easy to dismiss.
A diagnosis needs a proper biopsy of the node — not a needle aspirate alone. Persistence is what turns a swollen gland into a reason to investigate.
Understanding Lymphoma
The subtype — confirmed on biopsy — decides whether lymphoma is treated for cure now, or watched until it needs treating.
Hodgkin lymphoma
Hodgkin lymphoma is defined by Reed-Sternberg cells on biopsy and is one of oncology's success stories — most patients are cured, even with advanced disease. Staging uses PET-CT. Early-stage disease may be treated with a short course of chemotherapy plus radiation; advanced disease uses multi-agent chemo such as ABVD, with PET response guiding how much treatment is needed. Relapsed disease may need salvage chemo, autologous transplant, or newer immunotherapies (brentuximab vedotin, checkpoint inhibitors).
Aggressive NHL — DLBCL
Diffuse large B-cell lymphoma is the most common aggressive non-Hodgkin lymphoma. It grows quickly and needs prompt treatment — but it is curable in the majority of patients with R-CHOP (rituximab plus chemotherapy). Relapsed or refractory disease may be treated with salvage chemotherapy and autologous transplant, or with CD19-directed CAR-T cell therapy, which has become a standard option.
Indolent NHL — follicular & others
Indolent lymphomas such as follicular lymphoma are slow-growing. They are usually very controllable over many years, but not routinely cured. Asymptomatic patients may be observed ("watch and wait"); treatment — rituximab with or without chemotherapy — begins when there are symptoms, rapid growth, or organ compromise. The subtype is confirmed by immunohistochemistry and sometimes molecular testing.
Relapsed disease, transplant & CAR-T
Relapsed or refractory B-cell lymphoma may qualify for autologous transplant after salvage chemotherapy, or for CAR-T cell therapy in selected cases. Planning requires a careful review of prior regimens, PET response, and centre capabilities. See the CAR-T page for how engineered T-cells work and what the process involves.
Diagnosis — biopsy & staging
Diagnosis requires an excisional or core biopsy of an enlarged node — not fine-needle aspiration alone, which often cannot subtype lymphoma reliably. PET-CT and, in some cases, a bone marrow biopsy are used for staging. See the hemato-oncology page for a video on bone marrow biopsy when marrow assessment is needed.
Dr. Danthala's Approach
Lymphoma is often very curable — which makes getting the first plan right especially important. Three principles guide it.
-
Get the diagnosis exactly right
A proper biopsy and expert haematopathology come first. With dozens of subtypes that look similar but behave differently, an exact diagnosis is the difference between cure and mistreatment.
-
Treat for cure where cure is the goal
For Hodgkin lymphoma and aggressive NHL, the aim is cure — so treatment is delivered on schedule and at full effective dose, with PET imaging used to confirm response and avoid both under- and over-treatment.
-
Know when not to treat
For indolent lymphoma, "watch and wait" is an evidence-based plan, not inaction. Starting treatment too early adds side effects without adding years — so observation, with clear triggers to treat, is often the right call.
Treatment Options
Lymphoma is treated with systemic therapy (chemotherapy, immunotherapy, targeted drugs), sometimes radiation for localized disease, and — for relapse — transplant or CAR-T. The mix is built around subtype and stage.
ABVD, R-CHOP, and rituximab
For most lymphomas, combination chemotherapy is the backbone — ABVD for Hodgkin, R-CHOP for many aggressive B-cell NHLs. Adding the anti-CD20 antibody rituximab to chemotherapy was one of the biggest advances in lymphoma care and is standard for B-cell disease.
Brentuximab, BTK inhibitors, checkpoint drugs
Newer agents target specific pathways — brentuximab vedotin in Hodgkin and some T-cell lymphomas, BTK inhibitors in mantle-cell and other B-cell lymphomas, and checkpoint inhibitors in relapsed Hodgkin disease. These have expanded options well beyond traditional chemotherapy.
Involved-site radiation for localized disease
For early-stage Hodgkin lymphoma and some localized NHLs, a short course of radiation to the involved site — often after a few cycles of chemotherapy — can improve cure rates while keeping total treatment short. Modern techniques keep radiation tightly focused to spare healthy tissue.
For relapsed or refractory disease
When lymphoma relapses, an autologous bone marrow transplant after salvage chemotherapy can still be curative. For relapsed large B-cell lymphoma, CD19-directed CAR-T cell therapy offers durable remissions where chemotherapy has failed.
This is the menu, not the prescription. The right plan depends on the exact subtype, stage, and fitness — built with the patient in the room.
Frequently Asked Questions
Is lymphoma curable?
Many lymphomas are curable. Most Hodgkin lymphoma is cured even at advanced stage. Aggressive non-Hodgkin lymphomas such as DLBCL are curable in a majority of patients with R-CHOP. Indolent lymphomas such as follicular are usually very controllable over many years rather than routinely cured — which is why "controllable" and "curable" are both honest answers depending on the subtype.
What is the difference between Hodgkin and non-Hodgkin lymphoma?
They are distinct diseases. Hodgkin lymphoma is defined by Reed-Sternberg cells and tends to spread in an orderly way from one node group to the next; it is highly curable. Non-Hodgkin lymphoma is an umbrella term for dozens of subtypes that range from very aggressive (DLBCL) to very slow (follicular). The biopsy result — not the lump itself — tells them apart.
When is a transplant or CAR-T used for lymphoma?
Autologous transplant is common for relapsed or refractory lymphoma after salvage chemotherapy. CD19-directed CAR-T cell therapy is an option for relapsed or refractory large B-cell lymphoma — in some cases now used earlier in the disease course. Eligibility depends on age, fitness, response to prior therapy, and centre capabilities.
Do I really need a surgical biopsy — isn't a needle test enough?
For lymphoma, an excisional or core biopsy is usually needed. A fine-needle aspiration can suggest lymphoma but rarely gives enough tissue to identify the exact subtype, and subtype drives the whole treatment plan. Getting the right biopsy at the start avoids repeat procedures and delays.
How do I book a lymphoma consultation in Hyderabad?
Book at KIMS-Sunshine Begumpet via KIMS Hospitals (kimshospitals.com) or KIMS Sunshine (kimssunshine.co.in). Room 545, 5th Floor OPD, Mon–Sat 10 AM–5 PM. Evening clinic at Peoples Polyclinic, Manikonda — call +91 9346524080. A second opinion on the biopsy and plan is always welcome.
About Dr. Madhav Danthala
Dr. Madhav Danthala is a hemato-oncologist and bone marrow transplant physician at KIMS-Sunshine Hospitals, Begumpet, Hyderabad. He holds a DM in Medical Oncology from NIMS and completed fellowship training in leukemia and bone marrow transplant at Vancouver General Hospital, Canada. He has performed 300+ stem cell transplants and focuses on lymphoma, leukemia, myeloma, transplant, and second opinions.
Trusted guidelines & further reading
- Leukemia & Lymphoma Society — Lymphoma Patient information on Hodgkin and non-Hodgkin lymphoma subtypes and treatment.
- NCI / Cancer.gov — Lymphoma US National Cancer Institute treatment summaries for Hodgkin and non-Hodgkin lymphoma.
- ASCO / Cancer.Net — Non-Hodgkin Lymphoma American Society of Clinical Oncology patient education portal.